Heinrich Audebert, MD, Charité, Center for Stroke Research Berlin, Berlin, Germany, shares his insight into future treatments for hemorrhagic stroke, a condition where prognosis is poor and there is a lack of effective evidence-based treatments. Prof. Audebert is hopeful that the coming years will see the development of effective treatments for hemorrhagic stroke, as well as a critical shift towards pre-hospital care. Studies have shown the dispatch of mobile stroke units (MSUs) immediately after the onset of stroke symptoms to be beneficial. Thus, treatments may move to a prehospital setting to ensure patients receive proper treatment on time. Investigations into neuroprotection and neurorehabilitation are also growing fields. The major challenge will be applying these novel approaches to the right patients. This interview took place at the European Stroke Organisation Conference (ESOC), 2021.